Charlée Nardin

1.4k total citations
55 papers, 584 citations indexed

About

Charlée Nardin is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Charlée Nardin has authored 55 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 17 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Charlée Nardin's work include Melanoma and MAPK Pathways (13 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (11 papers). Charlée Nardin is often cited by papers focused on Melanoma and MAPK Pathways (13 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (11 papers). Charlée Nardin collaborates with scholars based in France, United States and Switzerland. Charlée Nardin's co-authors include F. Aubin, Jessica Gobbo, Carmen Garrido, Gaëtan Chanteloup, Valentin Dérangère, Laurent Arnould, Marie‐Paule Algros, Marine Cordonnier, E. Puzenat and Olivier Adotévi and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and European Heart Journal.

In The Last Decade

Charlée Nardin

46 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlée Nardin France 12 296 245 198 89 78 55 584
Robert Saddawi‐Konefka United States 13 207 0.7× 299 1.2× 431 2.2× 83 0.9× 54 0.7× 32 774
Tianxiao Xu China 14 294 1.0× 255 1.0× 107 0.5× 68 0.8× 110 1.4× 29 506
Kevin Lin United States 11 274 0.9× 352 1.4× 94 0.5× 70 0.8× 67 0.9× 19 739
Eiji Kiyohara Japan 13 302 1.0× 145 0.6× 104 0.5× 53 0.6× 175 2.2× 40 518
Bożena Romanowska‐Dixon Poland 15 172 0.6× 124 0.5× 85 0.4× 77 0.9× 26 0.3× 117 778
C. Soon Lee Australia 10 261 0.9× 269 1.1× 70 0.4× 45 0.5× 92 1.2× 10 506
Emilio Francesco Giunta Italy 15 210 0.7× 386 1.6× 96 0.5× 174 2.0× 82 1.1× 61 646
Sangeetha M. Reddy United States 15 256 0.9× 499 2.0× 248 1.3× 139 1.6× 169 2.2× 29 830
Konstanze Spieth Germany 14 206 0.7× 322 1.3× 133 0.7× 63 0.7× 59 0.8× 24 587
Keisuke Imafuku Japan 13 151 0.5× 342 1.4× 171 0.9× 107 1.2× 47 0.6× 46 577

Countries citing papers authored by Charlée Nardin

Since Specialization
Citations

This map shows the geographic impact of Charlée Nardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlée Nardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlée Nardin more than expected).

Fields of papers citing papers by Charlée Nardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlée Nardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlée Nardin. The network helps show where Charlée Nardin may publish in the future.

Co-authorship network of co-authors of Charlée Nardin

This figure shows the co-authorship network connecting the top 25 collaborators of Charlée Nardin. A scholar is included among the top collaborators of Charlée Nardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlée Nardin. Charlée Nardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nardin, Charlée, Arthur Schüller, Sandrine Hirschi, et al.. (2025). Immune checkpoint inhibitors use in lung transplant recipients: a case series and systematic review of literature. ESMO Open. 10(4). 104537–104537.
2.
Puzenat, E., et al.. (2024). Intracranial hemorrhage caused by dabrafenib and trametinib therapy for metastatic melanoma. Melanoma Research. 34(3). 280–282.
3.
Nardin, Charlée, Célèste Lebbé, Cécile Pagès, et al.. (2024). Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).. Journal of Clinical Oncology. 42(16_suppl). 9578–9578.
4.
Hammas, Karima, Charlée Nardin, Sylvie Boyer, et al.. (2023). Incidence du carcinome basocellulaire en France et tendances entre 1980 et 2019 : étude en population à partir de registres des cancers. 3(8). A103–A103. 1 indexed citations
5.
Gérard, E., Célèste Lebbé, Émilie Lanoy, et al.. (2023). 1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA. Annals of Oncology. 34. S683–S683. 3 indexed citations
6.
7.
Baldini, Capucine, E. Maubec, Christine Longvert, et al.. (2023). Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients. Cancers. 15(17). 4330–4330. 3 indexed citations
8.
Beylot‐Barry, M., G. Quéreux, Charlée Nardin, et al.. (2023). Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real‐world French study. Journal of the European Academy of Dermatology and Venereology. 37(9). 1777–1784. 13 indexed citations
9.
10.
Nardin, Charlée, Caroline Laheurte, E. Puzenat, et al.. (2021). Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma. Journal of Investigative Dermatology. 142(2). 435–444. 13 indexed citations
11.
Puzenat, E., et al.. (2021). A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience – Franche Comté, France. European Journal of Dermatology. 31(1). 101–103. 1 indexed citations
12.
13.
Dalle, Stéphane, M.‐T. Leccia, Laurent Mortier, et al.. (2021). Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort. Journal of the American Academy of Dermatology. 86(2). 345–352. 8 indexed citations
14.
Mansi, Laura, Laurie Spehner, Étienne Daguindau, et al.. (2021). Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients. European Journal of Cancer. 150. 1–9. 17 indexed citations
15.
Nardin, Charlée, et al.. (2021). Increase in American Joint Committee on Cancer Stage at Diagnosis for Patients with Skin Cancers after the COVID-19 Lockdown. Acta Dermato Venereologica. 102. adv00630–adv00630. 1 indexed citations
16.
Puzenat, E., et al.. (2021). Dissecting cellulitis of the scalp treated by tumour necrosis factor inhibitors: a case series. European Journal of Dermatology. 31(1). 81–85. 9 indexed citations
17.
Richard, M.‐A., E. Mahé, E. Brenaut, et al.. (2020). Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study. Dermatology Research and Practice. 2020. 1–3. 2 indexed citations
18.
Nardin, Charlée, et al.. (2019). Mastite granulomateuse idiopathique associée à un érythème noueux. Annales de Dermatologie et de Vénéréologie. 146(8-9). 571–576. 11 indexed citations
19.
Nardin, Charlée, Adam J. Widman, Lonny R. Levin, et al.. (2018). Mammalian pigmentation is regulated by a distinct cAMP-dependent mechanism that controls melanosome pH. Science Signaling. 11(555). 31 indexed citations
20.
Nardin, Charlée, et al.. (2016). Efficiency of an mTOR Inhibitor in Kasabach-Merritt Phenomenon with Indolent Tufted Angioma: A Case Report. Acta Dermato Venereologica. 97(7). 851–852. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Saddawi‐Konefka Breakdown of academic impact, for papers by Tianxiao Xu Breakdown of academic impact, for papers by Kevin Lin Breakdown of academic impact, for papers by Eiji Kiyohara Breakdown of academic impact, for papers by Bożena Romanowska‐Dixon Breakdown of academic impact, for papers by C. Soon Lee Breakdown of academic impact, for papers by Emilio Francesco Giunta Breakdown of academic impact, for papers by Sangeetha M. Reddy Breakdown of academic impact, for papers by Konstanze Spieth Breakdown of academic impact, for papers by Keisuke Imafuku
Rankless by CCL
2026